Published: 28 June 2024

University of Surrey and Cedars-Sinai sign new MoU

The University of Surrey and Cedars-Sinai, a world-renowned non-profit academic medical centre based in Los Angeles, California, signed a new memorandum of understanding (MoU) in spring 2024 to facilitate collaborative research, student and staff mobility, and the development of innovative medical education programmes.

The agreement builds upon initial discussions held in 2023 between Professor Paul A. Townsend, Executive Dean and Pro-Vice-Chancellor of the Faculty of Health and Medical Sciences at the University of Surrey, and Cedars-Sinai leadership. In September 2023, Heitham Hassoun, MD, Chief Executive of Cedars-Sinai International, visited the University of Surrey campus, including the Clinical Research Building for Sleep and Dementia, AURA Veterinary hospital. In January 2024, Russell Metcalfe Smith, Cedars-Sinai’s Executive Director of Simulation and Interprofessional Education, visited Surrey to discuss collaboration opportunities with the Clinical Simulation Centre at the University of Surrey.

Expanding horizons for future medical professionals

The MoU paves the way for exciting new initiatives, including Surrey student PhD mobility opportunities, potential future elective opportunities for medical students, joint curriculum development and faculty exchange programmes. Staff from both institutions will have the chance to collaborate on research projects and share best practices in medical education.

Shared vision for the future of healthcare

A commitment to global collaboration

This MoU underscores the University of Surrey and Cedars-Sinai's shared commitment to global collaboration in advancing medical knowledge. The combined expertise of both institutions will undoubtedly contribute to shaping the future of healthcare leadership.

Share what you've read?